SHL to give talk at the PDA Korea conference

Pda Korea News & Social Media 1200x630@2x

SHL will participate in this year’s conference hosted by the PDA Korea chapter titled the “2020 PDA Asia Pacific Aseptic Processing of Biopharmaceuticals” as a presenter on October 14, Korea Standard Time (KST). The three-day event runs from October 12-14.

As a first-time participant this year, SHL’s Senior Director of Commercial Operation Lyndon Wild will give a talk on how SHL’s Molly® autoinjector, built with a robust core technology, enables a mix of customizations for industrial design, manufacturing, as well as end user needs. The talk is titled “The “Customizable Platform” Paradox: A Flexible Design and Development Model for Platform Devices,” and will be delivered online by Lyndon on October 14, between 16:30-17:00 Korea Standard Time (KST).

About SHL Medical

SHL Medical is a world-leading solutions provider in the design, development, and manufacturing of advanced delivery devices such as autoinjectors, pen injectors, and advanced inhaler and wearable drug delivery systems. We offer final assembly, labeling, and packaging solutions for our drug delivery devices, and also provide contract manufacturing and engineering services for the production of complex medtech and industrial products.

With locations in Switzerland, Taiwan, Sweden, and the US, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for pharma and biotech clients globally. Significant investments in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high-volume and high-viscosity formulations and can be enhanced through digital implementations.

For additional information, visit

Media contact:


Related News